æ°åã³ããã¦ã¤ã«ã¹ã æ£é²ä¸¸ãå¹ãã æ£é²ä¸¸ã®ä¸»æåãã³ããã¦ã¤ã«ã¹ã®å¤èã¿ã³ãã¯è³ªï¼envelopeï¼ãç ´å£ããã
ã·ã£ã¢ããã£ã¼ãã£ã¼ããæ¬ãã£ã³ãã¼ã³ã§ã¯ãâã¸ãªã³å ¬å½å®çµ¦åâ風ã«ãã¶ã¤ã³ãããç¹è£½ã®ãææ²»ã¢ã¼ã¢ã³ããã§ã³ã±ã¼ã¹ãããã¬ã¼ã³ãããã¶ã¤ã³ã¯ãã·ã£ã¢å°ç¨ããã¸ãªã³å µç¨ãã¨ã·ã¼ã¯ã¬ããã®3種ãç¨æãããå¿åæéã«ãã£ã¦ã©ã¤ã³ããããç°ãªããæ¬æ¥3æ10æ¥ãã5æ18æ¥9æ59åã¾ã§ã®ç¬¬1å¼¾æéã§ã¯ãã·ã£ã¢å°ç¨ããã¸ãªã³å µç¨ããå200åã«ã5æ18æ¥10æãã7æ17æ¥15æã¾ã§ã®ç¬¬2å¼¾æéã§ã¯ãã·ã£ã¢å°ç¨ãã¨ã·ã¼ã¯ã¬ãããå200åã«ãã¬ã¼ã³ããããã 対象ååã¯ãã¢ã¼ã¢ã³ããã§ã³ã¬ã¼ã 88gããã¢ã¼ã¢ã³ããã§ã³ã¬ã¼ãæ¹è¶ 79gããã¢ã¼ã¢ã³ããã©ãã¯ãã§ã³ã¬ã¼ã 84gãããã«ããã¢ãã§ã³ã¬ã¼ã 9ç²ãããã«ããã¢ãã§ã³ã¬ã¼ãæ¹è¶ 9ç²ãããããã4ç¹ä»¥ä¸ã®è³¼å ¥ã¬ã·ã¼ãã1å£ã¨ãã¦ããã£ã³ãã¼ã³ã®ç¹è¨ãµã¤ãããã¬ã·ã¼ãç»åãã¢ãããã¼ãããå¿ è¦äºé ãå ¥åãããã¨ã§å¿åã§ããã詳細ã¯ç¹
å æãæ±äº¬é½å «çåå¸ã®è·¯ä¸ã§ç¹åãããã¯ã®ä¸ãæ©ãã¦ããå ¨ç²ã®ç·æ§ãéè¡äººã¨æ£é¢ããã¶ã¤ãããæ´è¨ãåããå³è¶³ãè¹´ãããã¨ããäºä»¶ãèµ·ããã¾ããããã®äºä»¶ã«ã¤ãã¦çè ã®èããè¿°ã¹ã¦ã¿ã¾ããã äºä»¶ã®æ¦è¦ ã京çå «çåé§ è¿ãã§å ¨ç²ã®å®®å·ç´ããï¼41ï¼ã20ã30代ã¨æãããç·æ§ã¨ã¶ã¤ãããä¸å·ããè¨èãæãã¤ããããäºä»¶ã¯å æãå ¨å½çã«è©±é¡ã¨ãªã£ãããæ±äº¬ã§ã®ãã©ãªã³ããã¯ãï¼å¹´å¾ã«è¿«ããªããè¦è¦é害è ã¸ã®ç解ãé²ãã§ããªããã¨ãæ®å¿µãã¨å®®å·ããã¯è©±ãã¦ããã çªç¶ã ã£ãã¨ãããæç¥çºã«ãããå®®å·ãããå¯çäºé·ãåãããå «çåè¦è¦é害è ç¦ç¥åä¼ãã¸ã®éå¤è·¯ãï¼ªï¼²å «çåé§ ããåããéä¸ã®äº¬çå «çåé§ è¿ãã§æ£é¢ããã¶ã¤ãã£ãããç½æãè½ã¨ãã¦ãã¾ããå°ãéããã£ãã®ã§æ¾ã£ã¦ãããã®ããªã¨æã£ããã§ããã¨å®®å·ããã ããæã£ã¦ããéã«å³è¶³ãè¹´ããããç®ãè¦ããªãã®ã«ä¸äººã§æ©ããªãã¨ãã£ãè¨èãæã
æ°åã³ããã¦ã¤ã«ã¹ææç ï¼COVID-19ï¼ã«ã¤ãã¦ã詳細ãã¤ææ°ã®ãã¥ã¼ã¹ã追ã£ã¦ããããã§ã¯ãªããä»æ¥ã®NHKã®å ±éã§ç¥ã£ãã ããªã®ã ããã¤ã¿ãªã¢ã§ã¯æ°ããªæ»è ãï¼æ¥ã§100人以ä¸å¢ãç´¯è¨366人ãææè ã7000人ãè¶ ãããããã大å¤ãªäºæ ã§ããã ãã®å ±éãèãã¦ãå人çã«ãã¤ããããæ ¹æ ããªãããã®å¢ãããäºæ³ãããã¨ããããå°ç¶ãã®æ¬§å·å¤§é¸ã§ã¯ãããªãè延ã¨ãªãã®ã§ã¯ãªãããã¨ã åæã«ããããæ ¹æ ã¯ãªãã®ã ãããä¸ã¤äºæ³ãããã¨ããããã¨ããããã§ã以ä¸ã®è©±ã¯ãããã°ã«ãããã¡ãªãå½ã¦ãã£ã½ãã®è©±ã§ã¯ãããããæªè³ªãªãããªããã¨ããªãã ããã¨ãæãã®ã§ãäºæ ã®æ¸¦ä¸ã§ãããªã®ãããªãã¨ãæã£ã¦ããæ¥æ¬äººãããã®ãã¨ãããä¸ã¤ã®è¨¼è¨ã¨ãã¦æ¸ãã¦ããããã å½ã¦ãã£ã½ãã§æã£ããã®ã®ãããªäºæ³ã¯ãæ¥æ¬ã®ãã®ææãããææã«æ¥éã«ãã¤ä»å½ã«é¡ããªãåæãè¿ãããããããªããã¨ããã
ç§æ¸ã«ããã®ãã²ã¼ï¼ããªã©æ´è¨ãæµ´ã³ãããªã©ããã¨ãã¦ãå·å®³ã¨æ´è¡ã®çãã§æ¸é¡éæ¤ï¼ä¸èµ·è¨´ï¼ã¨ãªãã17å¹´10æã®è¡é¢é¸ã§è½é¸ãããå è¡é¢è°å¡ã®è±ç°çç±åæ°ï¼45ï¼ã9æ¥ããã¸ãã¬ãç³»ããã¤ãã³ã°ãï¼æï½éæåå11æ55åï¼ã«çåºæ¼ãããåæ°ã¯09å¹´ã«æ°åã¤ã³ãã«ã¨ã³ã¶ã«å¯¾å¦ããå åå´ç¸å®åã¨ãã¦ãæ°åã³ããã¦ã¤ã«ã¹ã®ç¹éã§ã²ã¹ãã³ã¡ã³ãã¼ã¿ã¼ã¨ãã¦ç»å ´ããã è±ç°æ°ã¯é¨å以æ¥ãã¡ãã£ã¢ã«ã¯ãã»ã¼åºæ¼ãã¦ããããç»å ´ç´å¾ã¯ç·å¼µã®é¢æã¡ã ã£ããå¸ä¼ã®åä¸å¿ããããã¼ãã¼ãã®å ¬è¡è¡çå¦ãããåå¼·ãªãããã大éªã§ã®æ°åã¤ã³ãã«ã¨ã³ã¶ã®æã¯ãæ å½å¤äº¤å®ã¨ãã¦ä¸çä¿å¥æ©é¢ï¼WHOï¼ç¸æã«èª¿æ´ãããè¶ å°é家ãã¨ç´¹ä»ããããåä¸ããä¸æéããã£ãã¨ãããããã²2人ãç¨æãã¦ãã¾ãã®ã§ããã®ãã²ã¨è¨ã£ã¦ããã£ãããã¨è¨ããæ±å½åè±å¤«æ°ã¨ãã©ãã¯ãã¨ãã¼ãºå°æç«ä¸ãç´¹ä»ããã¨ãè±ç°æ°ã¯è¦ç¬ããããã®ç¯ã¯ã
å¿åºãé©ããã ãã®ï¼®ï¼¨ï¼«çªçµã¯æé ãã®ãã®ã ã ç§ã¯ãçªçµã®ä¸ã§æ£®å¤§è£ãè¿°ã¹ã¦ãã主張ãç©è¨¼ããã£ã¦ä¸ã¤ä¸ã¤è«ç ´ãã¦ããã ã»å¤å延é·ã§ããªãã¨æ¸ããæ¡æã¯ãªã ã»å¶åº¦åµè¨æã®éç¨ã¨çç±ãæããã§ãªã ç§ã®è«è¨¼ã¯ä¸ç§ãæ¾â¦ https://t.co/b9KvKuW9lC
ãªã¼ã¹ãã©ãªã¢ã§ãã¤ããæ£æ©ããã¦ããç·æ§ããææãçé£è»ãä¹ãæ¨ã¦ã¦éãã¦ãã容çè ãã¿ãã¯ã«ã§é»æ¢ããè¦å®ãæå©ããããè¦å¯ã¯ãåä¹ããªãã¾ã¾ç«ã¡å»ã£ããã®ç·æ§ã«æè¬ãä¼ãããã¨ãã¦æ¢ãã¦ããï¼æ åã®ã¿ï¼ã ãªã¼ã¹ãã©ãªã¢ã§ãã¤ããæ£æ©ããã¦ããç·æ§ããææã ã¯ã¤ã¼ã³ãºã©ã³ãè¦å¯ã5æ¥ã«å ¬éããæ åã容çè ã¯ãçãã ç½ã®ãã¨ã¿ã»ãã¤ã©ãã¯ã¹ã§éèµ°ããªããéããã éä¸ã§è»ãä¹ãæ¨ã¦ãèµ°ã£ã¦éãã¦ããã¨ããããã¤ããæ£æ©ããã¦ããç·æ§ãã¿ãã¯ã«ã§é»æ¢ã ã¤ãã¯ããã£ã½ãæ¯ããªããå¿æ´ã 容çè ã¯ãå¾ããæ¥ãè¦å®ã«ææãããã ç·æ§ã¨ã¤ãã¯åãåããã«å»ã£ã¦ãã£ãããè¦å¯ã¯æè¬ãä¼ãããã¨ãã¦æ¢ãã¦ããã¨ããã
æ°åã³ããã¦ã¤ã«ã¹ææçãã³ããã¯ã¯ãã³ã«ã¤ãã¦ã¯ãå¿ ã1次æ å ±ã¨ãã¦åçå´åçãé¦ç¸å®é¸ã®ã¦ã§ããµã¤ããªã©å ¬çæ©é¢ã§çºè¡¨ããã¦ããçºçç¶æ³ãQ&Aãç¸è«çªå£ã®æ å ±ãã確èªãã ãããâ»é常æã®ããããã¹ã¦ã®é¢é£è¨äºã«æ¬æ³¨ææ¸ããä¸æçã«åºãã¦ãã¾ãã 2020å¹´3æ8æ¥ å½ç«å½éå»çç 究ã»ã³ã¿ã¼ãå½éææçã»ã³ã¿ã¼ã忽é£è³¢å¿ ææçç·åæ å ±èªJ-IDEOã§ã¯ãæ¬èªå·å¤ã¨ãã¦å½ç«å½éå»çç 究ã»ã³ã¿ã¼ã®å¿½é£è³¢å¿å çã«ãããç·èª¬ãæ°åã³ããã¦ã¤ã«ã¹ææçï¼COVID-19ï¼ããå è¡å ¬éè´ãã¾ãã忽é£å çã«ç¾æç¹ã«ãããææ°ç¥è¦ãã¾ã¨ãã¦é ãã¾ããã ã3æ10æ¥æ´æ°ã æ¬æä¸ããã³æç®ãªã¹ãã®æç®çªå·ãã¯ãªãã¯ãããã¨ã§ãPubMedçã®åèè«ææ å ±ã«ã¢ã¯ã»ã¹åºæ¥ãããã«ãªãã¾ããï¼ä¸é¨æç®ã¯é対å¿ï¼ã ãã¤ã³ã ã»æ°åã³ããã¦ã¤ã«ã¹ææçï¼COVID-19ï¼ã¯SARS-CoV-2ã«ããå¼å¸å¨æ
ã©ã³ãã³ã°
ã©ã³ãã³ã°
ã©ã³ãã³ã°
ãªãªã¼ã¹ãé害æ å ±ãªã©ã®ãµã¼ãã¹ã®ãç¥ãã
ææ°ã®äººæ°ã¨ã³ããªã¼ã®é ä¿¡
j次ã®ããã¯ãã¼ã¯
kåã®ããã¯ãã¼ã¯
lãã¨ã§èªã
eã³ã¡ã³ãä¸è¦§ãéã
oãã¼ã¸ãéã
{{#tags}}- {{label}}
{{/tags}}